Healthcare
-
HealthStream’s Virsys12 Buy Signals A Strategic Shift Toward The Payer Market!
HealthStream acquires Virsys12 for $17M, expanding into the payer market with V12 Enterprise® and strengthening its credentialing suite as it…
Read More » -
Zepp Health’s Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play?
Zepp Health, best known for its Amazfit smartwatches, has taken a bold step in health-tech with its acquisition of Wild.AI’s…
Read More » -
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Phreesia is charting new territory with its recently announced $160 million all-cash acquisition of AccessOne Parent Holdings, a healthcare financing…
Read More » -
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share,…
Read More » -
Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine?
Waystar, a leading healthcare payments platform, has announced its plan to acquire health AI company Iodine Software for $1.25 billion…
Read More » -
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
DexCom has undergone a major strategic reset after a turbulent 2024, and all eyes are now on its bold shift…
Read More » -
Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened?
Hims & Hers Health saw its stock crash by over 35% in a matter of days after Novo Nordisk announced…
Read More » -
Healthcare Stocks: Once a Safe Bet, Healthcare Now Faces New Market Headwinds
Healthcare stocks have long been considered a safe and reliable bet for investors seeking stability during turbulent times.
Read More » -
SBC Medical Group: Dominating Japan’s Booming Aesthetic Market with Strong Financial Growth and Global Expansion Plans
Amidst this thriving landscape, SBC Medical Group Holdings (Nasdaq: SBC) has emerged as a leading provider in Japan, offering a…
Read More » -
TPOXX Failure is Massive-Opportunity for Nanoviricides’ NV-387 to Battle Clade 1/1b
Enter NanoViricides, Inc. (NYSE American: NNVC), a company at the forefront of developing groundbreaking solutions to combat viral infections. With…
Read More »
